ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,011,290,000 | -29.4% | 74,500 | +7.9% | 0.40% | -28.4% |
| Q4 2014 | $4,263,147,000 | +12.7% | 69,050 | -29.1% | 0.55% | +4.2% |
| Q3 2014 | $3,783,984,000 | +593.0% | 97,450 | +514.8% | 0.53% | +616.2% |
| Q2 2014 | $546,033,000 | -57.2% | 15,850 | -46.4% | 0.07% | -57.5% |
| Q1 2014 | $1,276,856,000 | +0.6% | 29,550 | -7.2% | 0.17% | -10.3% |
| Q4 2013 | $1,268,904,000 | +3.5% | 31,850 | -2.5% | 0.19% | -3.0% |
| Q3 2013 | $1,225,681,000 | +33.6% | 32,650 | -4.4% | 0.20% | +27.4% |
| Q2 2013 | $917,610,000 | – | 34,150 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |